Literature DB >> 9464184

Steroid-induced cataract: new perspective from in vitro and lens culture studies.

J E Dickerson1, E Dotzel, A F Clark.   

Abstract

The prevailing view regarding the mechanism of steroid cataract formation holds that glucocorticoids are covalently bound to lens proteins resulting in destabilization of the protein structure allowing further modification (i.e. oxidation) leading to cataract. Alternative hypotheses (e.g. that cataracts result from glucocorticoid receptor mediated effects) have been difficult to test since protein binding does in fact occur for many cataractogenic steroids. A glucocorticoid lacking the typical glucocorticoid hydroxy group at C21 (fluorometholone, FML), other steroids which can bind to proteins but lack glucocorticoid activity, and a glucocorticoid antagonist (RU486) have been utilized to discriminate between these two hypotheses. Purified bovine beta-crystallin incubated with three different 3H-steroids, dexamethasone (Dex), aldosterone or progesterone demonstrated that the C-21 hydroxyl group is not essential for steroid binding. Progesterone (with no C-21 OH) bound to the greatest extent. Pretreatment of the protein with aspirin to acetylate the free protein amino groups blocked this binding, demonstrating the probability of a Schiff base mechanism. Lens culture studies with the same three radiolabeled steroids demonstrated much the same result. Rat lenses cultured for 48 hr-11 days, demonstrated that loss of GSH is an early and significant effect of several glucocorticoids (Dex, prednisolone and FML) but is not seen with other non-glucocorticoid steroids. However, none of the steroids tested consistently produced lenticular opacification (i.e. cataracts) in this in vitro system, nor did they alter rubidium transport. We suggest that a mechanism other than covalent binding of steroids to lens proteins is responsible for glucocorticoid induced cataracts because: (1) non-glucocorticoids were demonstrated to bind lens proteins as well or better than the glucocorticoid Dex and (2) only glucocorticoids, and not other steroids, lowered lens reduced glutathione content which has been demonstrated to be associated with other forms of cataract.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9464184     DOI: 10.1006/exer.1997.0359

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  16 in total

Review 1.  Locally administered ocular corticosteroids: benefits and risks.

Authors:  Charles N J McGhee; Simon Dean; Helen Danesh-Meyer
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

2.  Loss of αB-crystallin function in zebrafish reveals critical roles in the development of the lens and stress resistance of the heart.

Authors:  Sanjay Mishra; Shu-Yu Wu; Alexandra W Fuller; Zhen Wang; Kristie L Rose; Kevin L Schey; Hassane S Mchaourab
Journal:  J Biol Chem       Date:  2017-11-21       Impact factor: 5.157

3.  Vehicle of triamcinolone acetonide is associated with retinal toxicity and transient increase of lens density.

Authors:  Wang Kai; Jiang Yanrong; Li Xiaoxin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-02-02       Impact factor: 3.117

Review 4.  Ophthalmic drug design based on the metabolic activity of the eye: soft drugs and chemical delivery systems.

Authors:  Nicholas Bodor; Peter Buchwald
Journal:  AAPS J       Date:  2005-12-07       Impact factor: 4.009

5.  High-resolution magic angle spinning 1H NMR spectroscopy of metabolic changes in rabbit lens after treatment with dexamethasone combined with UVB exposure.

Authors:  Oddbjørn Saether; Oystein Risa; Jitka Cejková; Jostein Krane; Anna Midelfart
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-10-13       Impact factor: 3.117

6.  Treatment of steroid-induced elevated intraocular pressure with anecortave acetate: a randomized clinical trial.

Authors:  Ingeborg Stalmans; David G Callanan; Monte S Dirks; Marlene R Moster; Alan L Robin; Joachim Van Calster; Sally A Scheib; Jaime E Dickerson; Theresa A Landry; Michael V W Bergamini
Journal:  J Ocul Pharmacol Ther       Date:  2012-08-03       Impact factor: 2.671

7.  Inhibition of glucocorticoid-induced alteration of vimentin by a glucocorticoid receptor antagonist RU486 in the organ-cultured rat lens.

Authors:  Guo-Li Xie; Hong Yan; Zi-Fan Lu
Journal:  Mol Vis       Date:  2011-01-06       Impact factor: 2.367

8.  Different experimental approaches in modelling cataractogenesis: An overview of selenite-induced nuclear cataract in rats.

Authors:  Zuzana Kyselova
Journal:  Interdiscip Toxicol       Date:  2010-03-29

9.  Proteomics analysis of water insoluble-urea soluble crystallins from normal and dexamethasone exposed lens.

Authors:  Lin Wang; DongRui Liu; Ping Liu; YongBin Yu
Journal:  Mol Vis       Date:  2011-12-28       Impact factor: 2.367

10.  Nanoceria Prevents Glucose-Induced Protein Glycation in Eye Lens Cells.

Authors:  Belal I Hanafy; Gareth W V Cave; Yvonne Barnett; Barbara K Pierscionek
Journal:  Nanomaterials (Basel)       Date:  2021-06-01       Impact factor: 5.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.